Psoriasis-Arthritis und axiale Spondyloarthritis: parallele Zulassung für Bimekizumab
Crossref DOI link: https://doi.org/10.1007/s15002-023-4361-8
Published Online: 2023-08-15
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kathmann, Wiebke
Text and Data Mining valid from 2023-08-01
Version of Record valid from 2023-08-01
Article History
First Online: 15 August 2023
Free to read: This content has been made available to all.